Profile photo Peter van Tintelen

Peter van Tintelen

Full Professor

Strategic program(s):

Research groups

Inherited heart disease (cardiogenetics)

Research aim

We aim to enhance patient and family lives impacted by inherited cardiomyopathies. Our efforts target gene and variant identification, disease mechanisms, factors influencing disease outcomes, therapy optimization, and exploration of novel therapies.

Go to group

Recent publications

Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant Carriers. Fahima Hassanzada, Mark Jansen, Freyja H M van Lint, Laurens P Bosman, Amand F Schmidt, Dennis Dooijes, Danny van de Sande, Bristi Miah, Saskia N van der Crabben, Arthur A M Wilde, Ronald H Lekanne Deprez, Rudolf A de Boer, Imke Christiaans, Jan D H Jongbloed, Harald T Jorstad, Folkert W Asselbergs, J Peter van Tintelen, Annette F Baas, Anneline S J M Te Riele
Circulation. Genomic and precision medicine, 2024, vol. 17
Performance of ARVC Risk Calculators in (Likely) Pathogenic Plakophilin-2 Variant Carriers Without Definite ARVC Diagnosis Steven A. Muller, Babken Asatryan, Brittney Murray, Crystal Tichnell, Moniek G.P.J. Cox, Ahmad S. Amin, Sing Chien Yap, Alessio Gasperetti, Richard T. Carrick, Julia Cadrin-Tourigny, Marish I.F.J. Oerlemans, Hugh Calkins, J. Peter Van Tintelen, Cynthia A. James, Anneline S.J.M. Te Riele
Circulation: Arrhythmia and Electrophysiology, 2024, vol. 18
Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction Anouk Achten, Steven A Muller, Sandra Sanders-van Wijk, Manon G van der Meer, Pim van der Harst, Peter van Tintelen, Anneline Sjm Te Riele, Vanessa van Empel, Marish Ifj Oerlemans, Christian Knackstedt
Annals of Medicine, 2024, vol. 56
Clinical features and outcomes in carriers of pathogenic desmoplakin variants Alessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, Brittney Murray, Mikael Laredo, Iris van der Schaaf, Ronald H Lekanne, Petros Syrris, Douglas Cannie, Crystal Tichnell, Chiara Cappelletto, Marta Gigli, Kristen Medo, Ardan M Saguner, Firat Duru, Nisha A Gilotra, Stefan Zimmerman, Robyn Hylind, Dominic J Abrams, Neal K Lakdawala, Julia Cadrin-Tourigny, Mattia Targetti, Iacopo Olivotto, Maddalena Graziosi, Moniek Cox, Elena Biagini, Philippe Charron, Michela Casella, Claudio Tondo, Momina Yazdani, James S Ware, Sanjay K Prasad, Leonardo Calò, Eric D Smith, Adam S Helms, Sophie Hespe, Jodie Ingles, Harikrishna Tandri, Flavie Ader, Giovanni Peretto, Stacey Peters, Ari Horton, Jess Yao, Sven Dittmann, Eric Schulze-Bahr, Maria Qureshi, Katelyn Young, Eric D Carruth, Chris Haggerty, Victoria N Parikh, Matthew Taylor, Luisa Mestroni, Arthur Wilde, Gianfranco Sinagra, Marco Merlo, Estelle Gandjbakhch, J Peter van Tintelen, Anneline S J M Te Riele, Perry M Elliott, Hugh Calkins, Cynthia A James
European heart journal, 2024, vol. 46, p.362-376
Healthcare professionals’ perspective on the acceptance of gene therapy Lian Y. Rekker, Erik Renkema, Femke Hilverda, Linda W. van Laake, Pieter A. Doevendans, Joost P.G. Sluijter, Pim van der Harst, J. Peter van Tintelen, Anneline S.J.M. te Riele
Heart Rhythm O2, 2024, vol. 5, p.747-749
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis Steven A Muller, Belén Peiró-Aventin, Giulia Biagioni, Giacomo Tini, Giulia Saturi, Christina Kronberger, Anouk Achten, Stephan Dobner, Wouter P Te Rijdt, Alessio Gasperetti, Anneline S J M Te Riele, Guerino G Varrà, Alberto Ponziani, Alexander Hirsch, Aldostefano Porcari, Manon G van der Meer, Mattia Zampieri, Pim van der Harst, Andreas Kammerlander, Elena Biagini, J Peter van Tintelen, Emanuele Barbato, Folkert W Asselbergs, Silvia Menale, Christoph Gräni, Marco Merlo, Michelle Michels, Christian Knackstedt, Christian Nitsche, Simone Longhi, Beatrice Musumeci, Francesco Cappelli, Pablo Garcia-Pavia, Marish I F J Oerlemans
European Journal of Heart Failure, 2024, vol. 26, p.2025-2034

External positions

Board member - Cardio genetica - Stichting Cardiomyopathie-Onderzoek Nederland

"member supervisory board, Stichting LEEFH (landelijk expertisecentrum erf.h.onderzoek fam HVZ) - supervising/advising board of directors - LEEFH Foundation

lid managementteam Durrer Cardiovasculair Research Centrum - geen - Netherlands Heart Institute

lid medische adviesraad - geen duidelijke - Contactgroep Marfan Nederland